Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
155 participants
OBSERVATIONAL
2020-03-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to determine the susceptibility pattern of our local isolated UPEC strains which is essential for optimal management of UTI.
* to evaluate the different virulence genes in UPEC isolates and their association with antibiotic resistance.
* to track common UPEC serogroups.
* to investigate the biofilm formation and the relationship between virulence genes and biofilm formation in UPEC strains isolated from patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
a Smptomatic Bacteriuria in Pregnancy
NCT03499561
Management of Sub-Clinical Bacteriuria in Pregnancy
NCT03275623
Examination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections
NCT01507974
Treatment of Asymptomatic Bacteriuria in Pregnancy
NCT02911662
Epidemiology of Abnormal Vaginal Discharge During Pregnancy
NCT04719754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group1
Group 1:pregnant women with cystitis
Talking a urine sample
Just taking a urine sample
Group2
Group 2: pregnant women with Pyelonephritis
Talking a urine sample
Just taking a urine sample
Group3
Group 3: pregnant women with asymptomatic bacteriuria
Talking a urine sample
Just taking a urine sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Talking a urine sample
Just taking a urine sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NSHussein
Demonstrator of medical microbiology and immunology. Faculty of medicine. Assiut university
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Urinary tract infection
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.